MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
HRYZ Biotech Co.
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center